During the past decade, Ortenau Klinikum Lahr-Ettenheim conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ortenau Klinikum Lahr-Ettenheim" #1 sponsor was "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 4 trials, followed by "University Hospital Tuebingen" with 2 trials sponsored, "AIO-Studien-gGmbH" with 1 trials sponsored, "PD Dr. med. Matthias Dollinger" with 1 trials sponsored and "University Hospital Freiburg" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ortenau Klinikum Lahr-Ettenheim" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Celgene" with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator, "STABIL - Statistische und Biometrische Lösungen" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Ortenau Klinikum Lahr-Ettenheim" are "Cholangiocarcinoma" (2 trials), "Gallbladder Cancer" (2 trials), "Hepatocellular Cancer" (2 trials), "Metastatic Breast Cancer" (2 trials) and "Oesophageal Cancer" (2 trials). Many other conditions were trialed in "Ortenau Klinikum Lahr-Ettenheim" in a lesser frequency.

Most popular intervention types in "Ortenau Klinikum Lahr-Ettenheim" are "Drug" (5 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "ATRA" (1 trials), "Aflibercept + mLV5FU2" (1 trials), "Carboplatin" (1 trials), "Decitabine" (1 trials) and "Doxorubicin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ortenau Klinikum Lahr-Ettenheim" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ortenau Klinikum Lahr-Ettenheim". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ortenau Klinikum Lahr-Ettenheim, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ortenau Klinikum Lahr-Ettenheim, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".